Please Wait
Applying Filters...
Menu
$ API Ref.Price (USD/KG) : 158Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 1Combivent

02 6ProAir

03 2Proair

04 10Ventolin

PharmaCompass

01

Brand Name : Ventolin

Albuterol

arrow
BioFlorida Conference
Not Confirmed

Brand Name : Ventolin

arrow
BioFlorida Conference
Not Confirmed

Albuterol

Main Therapeutic Indication : Respiratory Disorders

Currency : USD

2020 Revenue in Millions : 1,088

2019 Revenue in Millions : 1,300

Growth (%) : -16

blank

02

Brand Name : ProAir

Albuterol sulfate

arrow
BioFlorida Conference
Not Confirmed

Brand Name : ProAir

arrow
BioFlorida Conference
Not Confirmed

Albuterol sulfate

Main Therapeutic Indication : Respiratory Disorders

Currency : USD

2019 Revenue in Millions : 274

2018 Revenue in Millions : 397

Growth (%) : -31

blank

03

Brand Name : ProAir

Albuterol sulfate

arrow
BioFlorida Conference
Not Confirmed

Brand Name : ProAir

arrow
BioFlorida Conference
Not Confirmed

Albuterol sulfate

Main Therapeutic Indication : Respiratory Disorders

Currency : USD

2020 Revenue in Millions : 241

2019 Revenue in Millions : 274

Growth (%) : -12

blank

04

Brand Name : Ventolin

Albuterol

arrow
BioFlorida Conference
Not Confirmed

Brand Name : Ventolin

arrow
BioFlorida Conference
Not Confirmed

Albuterol

Main Therapeutic Indication : Respiratory Disorders

Currency : USD

2021 Revenue in Millions : 972

2020 Revenue in Millions : 1,075

Growth (%) : -9

blank

05

Brand Name : ProAir

Albuterol sulfate

arrow
BioFlorida Conference
Not Confirmed

Brand Name : ProAir

arrow
BioFlorida Conference
Not Confirmed

Albuterol sulfate

Main Therapeutic Indication : Respiratory Disorders

Currency : USD

2021 Revenue in Millions : 180

2020 Revenue in Millions : 241

Growth (%) : -25

blank

06

Brand Name : Ventolin

Albuterol

arrow
BioFlorida Conference
Not Confirmed

Brand Name : Ventolin

arrow
BioFlorida Conference
Not Confirmed

Albuterol

Main Therapeutic Indication : Respiratory Diseases

Currency : USD

2022 Revenue in Millions : 951

2021 Revenue in Millions : 972

Growth (%) : -2

blank

07

Brand Name : Ventolin

Albuterol

arrow
BioFlorida Conference
Not Confirmed

Brand Name : Ventolin

arrow
BioFlorida Conference
Not Confirmed

Albuterol

Main Therapeutic Indication : Respiratory Diseases

Currency : USD

2023 Revenue in Millions : 808

2022 Revenue in Millions : 951

Growth (%) : -3

blank

08

Brand Name : ProAir

Albuterol Sulfate

arrow
BioFlorida Conference
Not Confirmed

Brand Name : ProAir

arrow
BioFlorida Conference
Not Confirmed

Albuterol Sulfate

Main Therapeutic Indication : Respiratory Disorders

Currency : USD

2014 Revenue in Millions : 11.40%

2013 Revenue in Millions :

Growth (%) :

blank

09

Brand Name : Ventolin

Albuterol

arrow
BioFlorida Conference
Not Confirmed

Brand Name : Ventolin

arrow
BioFlorida Conference
Not Confirmed

Albuterol

Main Therapeutic Indication : Respiratory Disorders

Currency : USD

2015 Revenue in Millions : 944

2014 Revenue in Millions : 880

Growth (%) : -7%

blank

10

Brand Name : Ventolin

Albuterol

arrow
BioFlorida Conference
Not Confirmed

Brand Name : Ventolin

arrow
BioFlorida Conference
Not Confirmed

Albuterol

Main Therapeutic Indication : Respiratory Disorders

Currency : USD

2014 Revenue in Millions : 3.60%

2013 Revenue in Millions :

Growth (%) :

blank